These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11443144)

  • 1. Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway.
    Xin Y; Shang X; Sun X; Liu Y; Xu G; Xue G
    Evid Based Complement Alternat Med; 2021; 2021():2130229. PubMed ID: 34567204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
    Drosten M; Pützer BM
    J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.
    Yamazaki M; Straus FH; Messina M; Robinson BG; Takeda T; Hashizume K; DeGroot LJ
    Cancer Gene Ther; 2004 Jan; 11(1):8-15. PubMed ID: 14681722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
    Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
    Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective.
    Ball DW
    Thyroid; 2009 Jun; 19(6):547-50. PubMed ID: 19499986
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical review 131: Gene therapy for thyroid cancer: where do we stand?
    DeGroot LJ; Zhang R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2923-8. PubMed ID: 11443144
    [No Abstract]   [Full Text] [Related]  

  • 7. Sporadic medullary thyroid cancer.
    Harvey A; Pasieka JL
    Cancer Treat Res; 2010; 153():57-74. PubMed ID: 19957219
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
    Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
    Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.
    Drosten M; Pützer BM
    Nat Clin Pract Oncol; 2006 Oct; 3(10):564-74. PubMed ID: 17019434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of medullary thyroid cancer.
    Ball DW
    Minerva Endocrinol; 2011 Mar; 36(1):87-98. PubMed ID: 21460789
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.